Immunoturbidimetry Reagents Market, By Test Type (C-Reactive Protein (CRP) Reagents, Immunoglobulin Reagents, Complement System Reagents, Apolipoprotein Reagents, and HbA1c Reagents), By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5751
|
Published Date
July 2026
|
Pages
314
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Immunoturbidimetry Reagents Market size was valued at US$ 1,306.2 Million in 2025, expanding at a CAGR of 6.9% from 2026 to 2033.
The Immunoturbidimetry Reagents Market includes specialized reagents used in immunoturbidimetric assays, where the turbidity generated by antibody–antigen interactions is measured to determine the concentration of specific proteins and biomarkers in biological samples. These reagents are widely used with clinical chemistry analyzers for the detection and monitoring of biomarkers such as C-Reactive Protein (CRP), immunoglobulins, complement proteins, apolipoproteins, HbA1c, and other disease-related indicators associated with infectious diseases, cardiovascular disorders, autoimmune conditions, diabetes, and renal diseases.
The market growth is driven by the increasing global burden of chronic diseases, rising demand for rapid and automated diagnostic testing, expansion of clinical laboratory infrastructure, and growing adoption of high-throughput laboratory analyzers. According to the World Health Organization (WHO), noncommunicable diseases (NCDs) account for approximately 74% of all deaths globally, with cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases being the leading contributors. This rising disease burden is increasing the need for accurate biomarker detection and early diagnosis, supporting the adoption of immunoturbidimetric testing solutions. Furthermore, continuous advancements in reagent chemistry, laboratory automation, and diagnostic technologies, along with increasing healthcare expenditure and government-led health screening initiatives, are expected to create significant growth opportunities for the global Immunoturbidimetry Reagents Market during the forecast period. The expansion of preventive healthcare programs and the growing emphasis on early disease detection are further encouraging the adoption of reliable and efficient immunoturbidimetric diagnostic methods worldwide.
Immunoturbidimetry Reagents Market- Market Dynamics
Rising Prevalence of Chronic and Infectious Diseases Driving Immunoturbidimetry Reagents Market Growth
The increasing prevalence of chronic and infectious diseases is expected to drive the growth of the Immunoturbidimetry Reagents Market during the forecast period. Immunoturbidimetric assays are gaining widespread adoption in clinical laboratories due to their ability to accurately quantify important biomarkers, including C-Reactive Protein (CRP), immunoglobulins, complement proteins, apolipoproteins, and HbA1c. These diagnostic tests support the early detection and monitoring of various health conditions, including cardiovascular diseases, diabetes, autoimmune disorders, renal diseases, and bacterial infections, enabling timely medical interventions and improving patient outcomes. According to the World Health Organization (WHO), noncommunicable diseases (NCDs) account for approximately 41 million deaths annually worldwide, representing nearly 74% of global deaths, highlighting the growing need for efficient diagnostic solutions.
Increasing investments by governments and healthcare organizations in laboratory infrastructure development, along with the rising adoption of high-throughput clinical chemistry analyzers, are further accelerating the utilization of immunoturbidimetry reagents globally. Additionally, ongoing research and development activities focused on improving assay sensitivity, accuracy, and standardization of immunoturbidimetric testing procedures are expected to support market expansion. The growing demand for rapid, cost-effective, and reliable diagnostic solutions is encouraging healthcare providers to adopt advanced testing platforms capable of delivering accurate biomarker analysis, thereby driving continued growth in the immunoturbidimetry reagents sector.
Immunoturbidimetry Reagents Market- Segmentation Analysis:
The Global Immunoturbidimetry Reagents Market is segmented on the basis of Test Type, Application, End User, and Region.
Within the Test Type segment, C-Reactive Protein (CRP) Reagents account for a significant share of the Immunoturbidimetry Reagents Market, driven by their widespread application in the diagnosis and monitoring of inflammatory disorders, bacterial infections, cardiovascular diseases, and autoimmune conditions. CRP immunoturbidimetric assays are increasingly performed using automated clinical chemistry analyzers due to their ability to provide rapid, accurate, and reproducible quantitative results. For instance, in March 2025, Roche introduced the Tina-quant® Lipoprotein (a) Gen.2 immunoturbidimetric assay for its cobas® clinical chemistry analyzer portfolio. The assay is designed to support cardiovascular risk assessment by enabling reliable Lipoprotein (a) measurement in clinical laboratories, reflecting the ongoing advancements in immunoturbidimetric reagent solutions for automated diagnostic platforms. Meanwhile, HbA1c Reagents are expected to witness strong growth during the forecast period, supported by the rising global prevalence of diabetes and increasing demand for effective diabetes monitoring solutions. The growing emphasis on early diagnosis, disease management, and preventive healthcare is further contributing to the adoption of HbA1c testing through advanced immunoturbidimetric technologies.
Based on Application, the Clinical Chemistry segment holds a significant share of the Immunoturbidimetry Reagents Market due to the widespread adoption of immunoturbidimetric techniques for measuring protein biomarkers in routine diagnostic testing. These methods are extensively used in clinical laboratories for detecting and monitoring conditions such as cardiovascular diseases, autoimmune disorders, infectious diseases, diabetes, and kidney-related disorders. The increasing prevalence of chronic diseases and the growing need for rapid, automated, and reliable laboratory diagnostics are expected to further increase demand across these application areas. According to the World Health Organization (WHO), noncommunicable diseases are responsible for approximately 41 million deaths annually worldwide, representing nearly 74% of all global deaths, emphasizing the growing importance of efficient diagnostic technologies for early disease detection and management.
Based on End User, hospital laboratories account for a major share of the Immunoturbidimetry Reagents Market due to their high patient testing volumes, availability of automated clinical chemistry analyzers, and continuous investments in diagnostic infrastructure. Hospitals increasingly rely on immunoturbidimetric testing solutions for routine screening, disease monitoring, and emergency diagnostics because of their accuracy, speed, and compatibility with automated laboratory workflows. Independent diagnostic laboratories, academic and research institutes, and specialty clinics are also expected to experience steady growth as healthcare systems expand access to advanced diagnostic services and personalized disease management. According to the World Bank, global health expenditure has continued to rise as countries strengthen healthcare infrastructure and improve access to medical services, supporting increased adoption of advanced diagnostic technologies such as immunoturbidimetry-based testing solutions.
Immunoturbidimetry Reagents Market- Geographical Insights
North America accounts for the largest share of the Immunoturbidimetry Reagents Market, supported by its advanced healthcare infrastructure, widespread adoption of automated clinical chemistry analyzers, high diagnostic testing volumes, and the presence of leading in-vitro diagnostics (IVD) companies. The region’s growing burden of chronic diseases, along with continuous investments in laboratory modernization and diagnostic technologies, is further contributing to market growth. According to the Centers for Disease Control and Prevention (CDC), six out of ten adults in the United States have at least one chronic disease, while four out of ten adults have two or more chronic conditions. The increasing prevalence of chronic disorders is driving demand for biomarker-based testing, including CRP, HbA1c, immunoglobulin, and apolipoprotein analysis, thereby supporting the adoption of immunoturbidimetry reagents across clinical laboratories.
Europe represents a significant market for Immunoturbidimetry Reagents due to its well-established clinical laboratory infrastructure, supportive healthcare systems, strong focus on preventive care, and increasing investments in early disease detection. Governments across the region are emphasizing improvements in healthcare accessibility, diagnostic capabilities, and disease management programs, which are encouraging the adoption of advanced laboratory testing solutions. According to the European Commission, the EU4Health Programme (2021–2027) has allocated €5.3 billion to strengthen healthcare systems, improve disease prevention, and enhance diagnostic capabilities across European Union member states. These initiatives are expected to support the expansion of automated clinical testing platforms and increase the use of immunoturbidimetric assays for cardiovascular, infectious, autoimmune, and metabolic disease diagnostics throughout the region.
Immunoturbidimetry Reagents Market- Competitive Landscape:
The Immunoturbidimetry Reagents Market is highly competitive, with leading in-vitro diagnostics (IVD) companies focusing on product innovation, assay standardization, and the expansion of automated clinical chemistry testing portfolios. Key players operating in this market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter (Danaher Corporation), DiaSys Diagnostic Systems GmbH, Randox Laboratories Ltd., HORIBA, Ltd., Sekisui Diagnostics, Sentinel Diagnostics S.r.l., and FUJIFILM Wako Pure Chemical Corporation. These companies are strengthening their market presence through the development of advanced reagents, analyzer-compatible assays, strategic collaborations, regulatory approvals, and improvements in diagnostic performance. Continuous advancements in high-sensitivity immunoturbidimetric reagents, laboratory automation, and clinical chemistry platforms are enabling manufacturers to enhance testing accuracy, efficiency, and scalability.
Recent Developments:
- In March 2025, Medical & Biological Laboratories (MBL) entered into a licensing agreement with Agappe Diagnostics to transfer latex immunoturbidimetric reagent manufacturing technology and supply in-vitro diagnostic raw materials. The collaboration enabled Agappe to manufacture high-quality latex reagents in India, strengthening domestic diagnostic capabilities while supporting the availability of standardized and cost-effective clinical testing solutions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthineers AG
- Beckman Coulter, Inc. (Danaher Corporation)
- Thermo Fisher Scientific Inc.
- DiaSys Diagnostic Systems GmbH
- Randox Laboratories Ltd.
- HORIBA, Ltd.
- Sekisui Diagnostics
- Sentinel Diagnostics S.r.l.
- FUJIFILM Wako Pure Chemical Corporation
- BioSystems S.A.
- Mindray Bio-Medical Electronics Co., Ltd.
- Tosoh Corporation
- Shenzhen Dirui Industrial Co., Ltd.
- HUMAN Gesellschaft für Biochemica und Diagnostica mbH
- Trinity Biotech plc
- DiaSorin S.p.A.
- QuidelOrtho Corporation
- BÜHLMANN Laboratories AG
- Werfen
- Zybio Inc.
- Maccura Biotechnology Co., Ltd.
- Beijing Strong Biotechnologies, Inc.
- Shanghai Kehua Bio-Engineering Co., Ltd.
- Others
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- C-Reactive Protein (CRP) Reagents
- Immunoglobulin Reagents
- Complement System Reagents
- Apolipoprotein Reagents
- HbA1c Reagents
- Others
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Clinical Chemistry
- Autoimmune Disease Testing
- Cardiovascular Disease Testing
- Infectious Disease Testing
- Diabetes Testing
- Nephrology Testing
- Others
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospital Laboratories
- Independent Diagnostic Laboratories
- Academic & Research Institutes
- Specialty Clinics
- Others
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Immunoturbidimetry Reagents Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Immunoturbidimetry Reagents Market Snippet by Test Type
2.1.2. Immunoturbidimetry Reagents Market Snippet by Application
2.1.3. Immunoturbidimetry Reagents Market Snippet by End User
2.1.4. Immunoturbidimetry Reagents Market Snippet by Country
2.1.5. Immunoturbidimetry Reagents Market Snippet by Region
2.2. Competitive Insights
3. Immunoturbidimetry Reagents Key Market Trends
3.1. Immunoturbidimetry Reagents Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Immunoturbidimetry Reagents Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Immunoturbidimetry Reagents Market Opportunities
3.4. Immunoturbidimetry Reagents Market Future Trends
4. Immunoturbidimetry Reagents Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Immunoturbidimetry Reagents Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Immunoturbidimetry Reagents Market Landscape
6.1. Immunoturbidimetry Reagents Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Immunoturbidimetry Reagents Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2025 & 2033 (%)
7.1.2. C-Reactive Protein (CRP) Reagents
7.1.3. Immunoglobulin Reagents
7.1.4. Complement System Reagents
7.1.5. Apolipoprotein Reagents
7.1.6. HbA1c Reagents
7.1.7. Others
8. Immunoturbidimetry Reagents Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Clinical Chemistry
8.1.3. Autoimmune Disease Testing
8.1.4. Cardiovascular Disease Testing
8.1.5. Infectious Disease Testing
8.1.6. Diabetes Testing
8.1.7. Nephrology Testing
8.1.8. Others
9. Immunoturbidimetry Reagents Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
9.1.2. Hospital Laboratories
9.1.3. Independent Diagnostic Laboratories
9.1.4. Academic & Research Institutes
9.1.5. Specialty Clinics
9.1.6. Others
10. Immunoturbidimetry Reagents Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. Immunoturbidimetry Reagents Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Immunoturbidimetry Reagents Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Immunoturbidimetry Reagents Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Immunoturbidimetry Reagents Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Immunoturbidimetry Reagents Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Immunoturbidimetry Reagents Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. F. Hoffmann-La Roche Ltd.
11.2.2. Abbott Laboratories
11.2.3. Siemens Healthineers AG
11.2.4. Beckman Coulter, Inc. (Danaher Corporation)
11.2.5. Thermo Fisher Scientific Inc.
11.2.6. DiaSys Diagnostic Systems GmbH
11.2.7. Randox Laboratories Ltd.
11.2.8. HORIBA, Ltd.
11.2.9. Sekisui Diagnostics
11.2.10. Sentinel Diagnostics S.r.l.
11.2.11. FUJIFILM Wako Pure Chemical Corporation
11.2.12. BioSystems S.A.
11.2.13. Mindray Bio-Medical Electronics Co., Ltd.
11.2.14. Tosoh Corporation
11.2.15. Shenzhen Dirui Industrial Co., Ltd.
11.2.16. HUMAN Gesellschaft für Biochemica und Diagnostica mbH
11.2.17. Trinity Biotech plc
11.2.18. DiaSorin S.p.A.
11.2.19. QuidelOrtho Corporation
11.2.20. BÜHLMANN Laboratories AG
11.2.21. Werfen
11.2.22. Zybio Inc.
11.2.23. Maccura Biotechnology Co., Ltd.
11.2.24. Beijing Strong Biotechnologies, Inc.
11.2.25. Shanghai Kehua Bio-Engineering Co., Ltd.
11.2.26. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthineers AG
- Beckman Coulter, Inc. (Danaher Corporation)
- Thermo Fisher Scientific Inc.
- DiaSys Diagnostic Systems GmbH
- Randox Laboratories Ltd.
- HORIBA, Ltd.
- Sekisui Diagnostics
- Sentinel Diagnostics S.r.l.
- FUJIFILM Wako Pure Chemical Corporation
- BioSystems S.A.
- Mindray Bio-Medical Electronics Co., Ltd.
- Tosoh Corporation
- Shenzhen Dirui Industrial Co., Ltd.
- HUMAN Gesellschaft für Biochemica und Diagnostica mbH
- Trinity Biotech plc
- DiaSorin S.p.A.
- QuidelOrtho Corporation
- BÜHLMANN Laboratories AG
- Werfen
- Zybio Inc.
- Maccura Biotechnology Co., Ltd.
- Beijing Strong Biotechnologies, Inc.
- Shanghai Kehua Bio-Engineering Co., Ltd.
- Others
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- C-Reactive Protein (CRP) Reagents
- Immunoglobulin Reagents
- Complement System Reagents
- Apolipoprotein Reagents
- HbA1c Reagents
- Others
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Clinical Chemistry
- Autoimmune Disease Testing
- Cardiovascular Disease Testing
- Infectious Disease Testing
- Diabetes Testing
- Nephrology Testing
- Others
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospital Laboratories
- Independent Diagnostic Laboratories
- Academic & Research Institutes
- Specialty Clinics
- Others
GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
